Valuation: EMVision Medical Devices Ltd

Market Cap 152M 106M 93.18M 86.5M 79.49M 150M 10.26B 1.03B 403M 5.02B 399M 391M 17.35B P/E 2026 *
-16.7x
P/E 2027 * -14.5x
Enterprise Value 152M 106M 93.18M 86.5M 79.49M 150M 10.26B 1.03B 403M 5.02B 399M 391M 17.35B EV / Sales 2026 *
27.6x
EV / Sales 2027 * 30.4x
Free-Float
66.78%
Yield 2026 *
-
Yield 2027 * -
1 day-0.61%
1 week-4.13%
Current month+7.26%
1 month+4.17%
3 months-10.47%
6 months-8.71%
Current year-8.71%
1 week 1.59
Extreme 1.59
1.7
1 month 1.47
Extreme 1.47
1.76
Current year 1.47
Extreme 1.47
1.96
1 year 1.47
Extreme 1.47
2.43
3 years 1.18
Extreme 1.175
2.72
5 years 1.13
Extreme 1.13
3.35
10 years 0.28
Extreme 0.28
4.2
Manager TitleAgeSince
Chief Executive Officer - 01/07/2023
Director of Finance/CFO - 01/02/2026
Chief Tech/Sci/R&D Officer - 01/07/2023
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - 01/07/2018
Date Insider Type Main position Quantity % Market Cap.
4/23/26 A Buy

Director

10,000 0.0108%
1/2/26 A Expiration

Chairman

300,000 0.3228%
11/18/25 A Free

Director

200,000 0.2176%
Change 5-day change 1-year change 3-year change Capi.($)
-0.61%-4.13%-6.34%+34.85% 106M
+0.57%-1.65%+23.11%-6.36% 196B
+0.07%-10.78%-5.67%-29.99% 126B
-2.68%-12.41%-33.33%+1.20% 120B
-0.51%-0.16%-58.35%-19.17% 63.87B
-0.21%-3.32%+10.58%-8.86% 48.58B
-1.23%-2.96%-26.66%-33.41% 43.93B
+0.45%-0.93%+14.86%+4.58% 37.69B
+0.89%-1.09%+29.00%+28.44% 36.41B
-0.86%+1.99%+87.07%+0.20% 28.88B
Average -0.12%-3.76%+3.43%-2.85% 70.14B
Weighted average by Cap. +0.11%-4.99%-0.65%-9.67%

Financials

2026 *2027 *
Net sales 5.5M 3.85M 3.37M 3.13M 2.88M 5.42M 371M 37.29M 14.6M 182M 14.45M 14.13M 628M 5M 3.5M 3.07M 2.85M 2.61M 4.93M 338M 33.9M 13.27M 165M 13.13M 12.85M 571M
Net income -9.1M -6.37M -5.58M -5.18M -4.76M -8.97M -614M -61.7M -24.15M -301M -23.9M -23.39M -1.04B -12M -8.4M -7.36M -6.83M -6.28M -11.83M -810M -81.36M -31.84M -396M -31.52M -30.84M -1.37B
Net Debt - -
Logo EMVision Medical Devices Ltd
EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.
Employees
-
Date Price Change Volume
23/07/26 A$1.625 -0.61% 1,007
22/07/26 A$1.635 -0.30% 36,913
21/07/26 A$1.640 -2.09% 53,327
20/07/26 A$1.675 +3.40% 46,481
17/07/26 A$1.620 -4.42% 30,981
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.635AUD
Average target price
3.150AUD
Spread / Average Target
+92.66%

Annual profits - Rate of surprise